# Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

> **NCT00372489** · PHASE2 · TERMINATED · sponsor: **Affymax** · enrollment: 81 (actual)

## Conditions studied

- Chronic Renal Failure
- Chronic Kidney Disease
- Anemia

## Interventions

- **DRUG:** peginesatide

## Key facts

- **NCT ID:** NCT00372489
- **Lead sponsor:** Affymax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 81 (ACTUAL)
- **Why stopped:** Due to more robust long-term data generated in other active-controlled studies
- **Last updated:** 2012-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00372489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00372489, "Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00372489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*